Gilead Sciences, Inc. $GILD Shares Sold by Triglav Investments D.O.O.
Triglav Investments D.O.O. trimmed its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 21.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,000 shares of the biopharmaceutical company’s stock after selling 4,387 shares during the quarter. Triglav Investments D.O.O.’s holdings in […]
13 Jul 07:06 · The Cerbat Gem